Risks of statin use during pregnancy: a systematic review (Q34584493)

3 August 2017

1 reference

title

Risks of statin use during pregnancy: a systematic review (English)

1 reference

Facundo Garcia-Bournissen

3 August 2017

1 reference

series ordinal

2

object named as

Facundo Garcia-Bournissen

0 references

Gideon Koren

series ordinal

3

object named as

Gideon Koren

1 reference

3 August 2017

Aleksey Kazmin

1

1 reference

PubMed ID

17977494

3 August 2017

Facundo Garcia-Bournissen

series ordinal

2

1 reference

3 August 2017

1 November 2007

1 reference

Journal of Obstetrics and Gynaecology Canada

3 August 2017

1 reference

3 August 2017

29

1 reference

3 August 2017

906-908

1 reference

3 August 2017

11

1 reference

Who should receive a statin these days? Lessons from recent clinical trials

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Central nervous system and limb anomalies in case reports of first-trimester statin exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Effects of reduced maternal lipoprotein-cholesterol availability on placental progesterone biosynthesis in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

HMG-CoA reductase inhibitors: role in normal and malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Simvastatin has deleterious effects on human first trimester placental explants

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

2005 Josef Warkany lecture: Clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Reporting bias in retrospective ascertainment of drug-induced embryopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Pregnancy outcomes after maternal exposure to simvastatin and lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

Risk of congenital anomalies in pregnant users of statin drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932656-1

7 January 2021

10.1016/S1701-2163(16)32656-1

Identifiers

DOI

0 references

PubMed ID

17977494

1 reference

PubMed ID

17977494